SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-000197
Filing Date
2023-02-07
Accepted
2023-02-07 16:07:14
Documents
15
Period of Report
2023-02-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a53305227.htm   iXBRL 8-K 33501
2 EXHIBIT 99.1 a53305227ex991.htm EX-99.1 205521
3 EXHIBIT 99.2 a53305227ex992.htm EX-99.2 76780
7 logo.jpg GRAPHIC 11713
  Complete submission text file 0001157523-23-000197.txt   496042

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA usna-20230207.xsd EX-101.SCH 3914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE usna-20230207_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE usna-20230207_pre.xml EX-101.PRE 16036
9 EXTRACTED XBRL INSTANCE DOCUMENT a53305227_htm.xml XML 4080
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 23595111
SIC: 2833 Medicinal Chemicals & Botanical Products